Abstract
Induction of polyamine biosynthetic activity and the subsequent increases in intracellular polyamine pools are well documented components of the proliferative response (reviewed in 1–3). Indeed, several lines of evidence clearly indicate that sustained polyamine biosynthesis is a critical component of cell growth and not simply a consequence of it (2,4). In many ways, the association of polyamines with cell growth and, in particular, the properties of the enzyme proteins themselves bear intriguing resemblance to proto-oncogenes and their encoded products. Two key biosynthetic enzymes, ornithine and S-adenosylmethionine decarboxylase (ODC and AdoMetDC, respectively), are extremely short-lived with half-lives of less than 1 hr, highly inducible and subject to sensitive regulatory control. Increases in their activities are invariably associated with the very early stages of cell growth and, somewhat less consistently, with tumor promotion (5,6). Although the most illustrative of the enzymes in this respect, ODC, has not been shown to have transforming capabilities, cells which overexpress the enzyme can be endowed with increased proliferative potential (7) and/or tissue invasiveness (8). Moreover, induction of the enzyme, like certain of the proto-oncogenes, is known to be critically important for initiating and sustaining cell proliferation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Janne J, Poso H, Raina, A: Polyamines in rapid growth and cancer. Biochim. Biophys. Acta 473:241–293, 1978.
Porter CW, Sufrin JR: Interference with polyamine biosynthesis and/or function by analogs of polyamines or methionine as a potential anticancer chemotherapeutic strategy: A review. Anticancer Res. 6:525–542, 1986.
Pegg AE: Perspectives in Cancer Research. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res. 48:759–774, 1988.
Porter CW, Bergeron RJ: Enzyme regulation as an approach to interference with polyamine biosynthesis — an alternative to enzyme inhibition. In: Advances in Enzyme Regulation. G Weber (ed), Pergamon Press, New York and Oxford, Vol. 27, pp. 57–79, 1988.
Kingsnorth AN, King WWK, Diekema KA et al: Inhibition of ornithine decarboxylase with 2-difluoromethylornithine: Reduced incidence of dimethylhydrazine-induced colon tumors in mice. Cancer Res. 43:2545–2549, 1983.
O'Brien TG, Simsiman RC, Boutwell RK: Induction of the polyamine-biosynthetic enzymes in mouse epidermis by tumor-promoting agents. Cancer Res. 35:1662–1670, 1975.
Sistonen L, Keski-Oja J, Ulmanen I et al: Dose effects of transfected c-Ha-ras Val 12 oncogene in transformed cell clones. Exp. Cell Res. 168:518–530, 1987.
Alhonen-Hongisto L, Kallio A, Sinervirta R et al: Tumorigenicity, cell-surface glycoprotein changes and ornithine decarboxylase gene pattern in Ehrlich ascites-carcinoma cells. Biochem. J. 229:711–715, 1985.
Mamont PS, Duchesne M-C, Grove J, Bey P: Antiproliferative properties of DL-α-difluoromethylornithine in cultured cells. A consequence of irreversible inhibition of ornithine decarboxylase. Biochem. Biophys. Res. Commun. 81:58–66, 1978.
Schechter PJ, Barlow JLR, Sjoerdsma A: Clinical aspects of inhibition of ornithine decarboxylase with emphasis on therapeutic trials of eflornithine (DFMO) in cancer and protozoan diseases. In: Inhibition of Polyamine Metabolism. PP McCann, AE Pegg, A Sjoerdsma (eds), Academic Press, New York, pp. 345–364, 1987.
Porter CW, Bergeron RJ: Regulation of polyamine biosynthetic activity by spermidine and spermine analogs — a novel antiproliferative strategy. Progress in Polyamine Research. V Zappia, AE Pegg (eds), Plenum Press, New York, pp. 677–690, 1988.
Verma AK: The enzyme-activated irreversible inhibitor of ornithine decarboxylase, DL-α-difluoromethylornithine: A chemopreventive agent. Preventative Medicine 18:646–652, 1989.
Park MH, Cooper HL, Folk JE: Identification of hypusine, an unusual amino acid, in a protein from human lymphocytes and of spermidine as its biosynthetic precursor. Proc. Natl. Acad. Sci. U.S.A. 78:2869–2873, 1981.
Park MH, Liberato DJ, Yergey AL, Folk JE: The biosynthesis of hypusine (N'-[4-amino-2-hydroxybuty1]lysine). Alignment of the butylamine segment and source of the secondary amino nitrogen. J. Biol. Chem. 257:12123–12127, 1984.
Kramer DL, Khomutov RM, Bukin YV et al: Cellular characterization of a new irreversible inhibitor of S-adenosylmethionine decarboxylase and its use in determining the relative abilities of individual polyamines to sustain growth and viability of L1210 cells. Biochem. J. 259:325–331, 1989.
Seiler N: Functions of polyamine acetylation. Can. J. Physiol. Pharmacol 65:2024–2035, 1987.
Seiler N, Dezeure F: Polyamine transport in mammalian cells. Int. J. Biochem. 22:211–218, 1990.
Alhonen-Hongisto L: Regulation of S-adenosylmethionine decarboxylase by polyamines in Ehrlich ascites-carcinoma cells grown in culture. Biochem. J. 190:747–754, 1980.
Clark JL, Fuller JL: Regulation of ornithine decarboxylase in 3T3 cells by putrescine and spermidine: Indirect evidence for transiational control. Biochem. 14:4403–4409, 1975.
Bergeron RJ: Synthesis and solution structure of microbial siderophores. Acc. Chem. Res. 19:105–113, 1986.
Porter CW, Cavanaugh Jr. PF. Stolowich N et al: Biological properties of N4 — and N1, N8-spermidine derivatives in cultured L1210 leukemia cells. Cancer Res. 45:2050–2057, 1985.
Porter CW, McManis J, Casero RA, Bergeron RJ: Relative abilities of bis(ethyl) derivatives of putrescine, spermidine and spermine to regulate polyamine biosynthesis and inhibit cell growth. Cancer Res. 47:2821–2825, 1987.
Vertino PM, Bergeron RJ, Cavanaugh PF Jr, Porter CW: Structural determinants of spermidine-DNA interactions. Biopolymers 26:691–703, 1987.
Bergeron RJ, Neims AH, McManis JS et al: Synthetic polyamine analogues as antineoplastics. J. Med. Chem. 31:1183–1190, 1988.
Porter CW, Berger FG, Pegg AE et al: Regulation of ornithine decarboxylase activity by spermidine and the spermidine analog, N1,N8-bis(ethyl)-spermidine (BES). Biochem. J. 242:433–440, 1987.
Porter CW, Pegg AE, Ganis B, et al: Combined regulation of ornithine an S-adenosylmethionine decarboxylases by spermine and the spermine analog, N1,N12-bis(ethyl)spermine. Biochemical Journal 268:207–212, 1990.
Pegg AE, Madhubala R, Kameji T, Bergeron RJ: Control of ornithine decarboxylase activity in-difluoromethylornithine-resistant L1210 cells by polyamines and synthetic analogues. J. Biol. Chem. 263:11008–11014, 1988.
Seiler N, Heby O: Regulation of cellular polyamines in mammals. Acta Biochim. Biophys. Hung. 23:1–36, 1986.
Rechsteiner M: Regulation of enzyme levels by proteolysis: The role of PEST regions. In: Advances in Enzyme Regulation. G Weber, (ed), Pergamon Press, Volume 27, pp. 135–151, 1988.
Casero R, Go B, Theiss HW et al: Cytotoxic response of the relatively difluoromethylornithine-resistant human lung tumor cell line NCI H157 to the polyamine analogue N1, N8-bislethyl)-spermidine. Cancer Res. 47:3964–3967, 1987.
Casero RA Jr, Celano P, Ervin SJ et al: Differential induction of spermidine/spermine N1-acetyltransferase in human lung cancer cells by the bis(ethyl)polyamine analogues. Cancer Res. 49:3829–3833, 1989.
Porter CW, Ganis B, Libby PR, Bergeron RJ: Correlations between polyamine analog-induced increases in spermidine/ spermine N1-acetyltransferase activity, polyamine pool depletion and growth inhibition in human melanoma cell lines. Cancer Res. (In Press).
Bolkenius FN, Seiler N: Functions of polyamine acetylation. Int. J. Biochem. 13:287–292, 1981.
Pegg AE, Matsui I, Seely JE et al: Formation of putrescine in rat liver. Med. Biol. 59:327–333, 1981.
Mamont PS, Seiler N, Siat M et al: Metabolism of acetyl derivatives of polyamines in cultured polyamine-deficient rat hepatoma cells. Med. Biol. 59:347–353, 1981.
Wallace HM: Polyamine catabolism in mammalian cells: Excretion and acetylation. Med. Sci. Res. 15:1437–1440, 1987.
Erwin BG, Pegg AE: Regulation of spermidine spermine N1-acetyltransferase in L6 cells by polyamines and related compounds. Biochem. J. 238:581–587, 1986.
Libby PR, Bergeron RJ, Porter CW: Structure-function correlations of polyamine analog induced increases in spermidine/ spermine acetyltransferase activity. Biochem. Pharmacol. 38:1435–1442, 1989.
Libby PR, Henderson MA, Bergeron RJ, Porter CW: Major increases in spermidine/spermine-N'-acetyltransferase activity by spermine analogs and their relationship to polyamine depletion and growth inhibition of L1210 cells. Cancer Res. 49:6226–6231, 1989.
Pegg AE, Wechter R, Pakala R, Bergeron RJ: Effect of N1, N12-bis(ethyl)spermine and related compounds on growth and polyamine acetylation, content, and excretion in human colon tumor cells. J. Biol. Chem. 264:11744–11749, 1989.
Bergeron RJ, Hawthorne TR, Vinson JRT et al: Role of the methylene backbone in the antiproliferative activity of polyamine analogues on L1210 cells. Cancer Res. 49:2959–2964, 1989.
Libby PR, Ganis B, Bergeron RJ. Porter CW: Characterization of human spermidine/spermine N1-acetyltransferase purified from cultured melanoma cells. Arch. Biochem. Biophys. (In Press).
Phillips MA, Coffino P, Wang CC: Cloning and sequencing of the ornithine decarboxylase gene from trvpanosoma brucei. J. Biol. Chem. 262:8721, 1987.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer Science+Business Media New York
About this chapter
Cite this chapter
Porter, C.W., Kramer, D.L., Bernacki, R.J., Bergeron, R.J. (1992). Regulation of Polyamine Biosynthetic Activity and Homeostasis as a Novel Antiproliferative Strategy. In: Valeriote, F.A., Corbett, T.H., Baker, L.H. (eds) Cytotoxic Anticancer Drugs: Models and Concepts for Drug Discovery and Development. Developments in Oncology, vol 68. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3492-1_19
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3492-1_19
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6548-8
Online ISBN: 978-1-4615-3492-1
eBook Packages: Springer Book Archive